MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$143.81
Tradestie Score
55
Market Cap
$225.13B
P/E Ratio
116.2
Revenue Growth
0.1%
Analyst Upside
+8.3%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$258.66
|
$448.07B | 31.1 | 57 | Compare |
|
ABBV
ABBVIE INC.
|
$259.93
|
$431.71B | 74.5 | 56 | Compare |
|
PG
Procter & Gamble Company
|
$143.95
|
$358.52B | 21.9 | 50 | Compare |
|
NVO
Novo-Nordisk A/S
|
$37.40
|
$262.92B | 9.5 | 46 | Compare |
|
AZN
AstraZeneca PLC
|
$157.70
|
$261.56B | 24.0 | 48 | Compare |
|
NVS
Novartis AG
|
$141.05
|
$254.99B | 22.0 | 62 | Compare |
|
VZ
Verizon Communications
|
$45.98
|
$184.80B | 12.0 | 63 | Compare |
|
AMGN
Amgen Inc
|
$407.27
|
$160.70B | 26.3 | 46 | Compare |
|
PFE
Pfizer Inc.
|
$28.12
|
$154.70B | 37.5 | 45 | Compare |
|
GILD
Gilead Sciences Inc
|
$147.50
|
$137.92B | - | 51 | Compare |
More MRK Analysis
Data updated: Oct 02, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry